TEXT ONLY EQUIVALENT 2011
Strategic Planning Resources
For Healthcare Industry
Executives
Chemicals
Agrochemicals
Flavors & Fragrances
General Chemicals
Life Science Intermediates
Paints & Coatings
Specialty Chemicals
Company Profiles
Country
Analyses
Electronics
General Electronics
Personal Computers
Semiconductors
Food &
Beverage
Agricultural Chemicals
Beer
Dairy
Food & Drinks
Ingredients
In Vitro
Diagnostics
Alternative Scenarios
Automated Microbiology
Blood Banking
Cancer
Clinical Chemistry
Coagulation
Decentralized Testing
DNA Probes & Biochips
Genetic Testing
Hematology/Flow Cytometry
Histology & Cytology
Immunodiagnostics
Infectious Diseases
Molecular Diagnostics
Point-of-Care Testing
Strategic Planning
Top 10 Companies
Tumor Markers
Medical Devices
Diagnostic Imaging
Orthopedics
Pharmaceuticals &
Biotechnology
Animal Health
Biotechnology
Drug Delivery
Ethical Pharmaceuticals
Healthcare
Medical Equipment
Pharmaceutical Intermediates
Dear
Colleague,
August 17,
2011
Healthcare companies face enormous challenges during this
era of uncertainty and reform. The following reports were prepared by
Venture Planning Group and Business Insights to assist executives in
identifying high-growth markets and building winning capabilities: Three Alternative Scenarios Of the
Future In Vitro Diagnostics Market.....................255 pages, 32
tables, $11,800 Future Technological Breakthroughs..................................85 pages, 8
tables, $4,450
Strategic Implications of Emerging
Reimbursement, Technological And Market Trends..................................135 pages, 11 tables, $4,450
Advances in Drug-Diagnostic
Co-Development...............................102 pages,
$3,835
Diagnostics Pricing and Reimbursement
Strategies.............25 pages, 44 tables,
$3,835
To review related reports, visit In
Vitro Diagnostics and Medical
Devices collections.
Please let me know if you have any questions
concerning our publications, or would like to receive a proposal for a custom report tailored to your specific business objectives,
information needs, and budget.
Best regards, Robert
Fisher
Healthcare Research robert@vpgcorp.com +1 212
564 2838
VPGMarketResearch.com
VPG
Research Store
About
VPG
Clients
Please
remove my name from the distribution list.